Biora Therapeutics, Inc. (BIOR)
(Delayed Data from NSDQ)
$0.67 USD
+0.01 (0.87%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $0.67 0.00 (-0.52%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -0.61 |
Last EPS Surprise | -35.56% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.64 |
Next Year | -1.24 |
EPS (TTM) | -3.46 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 0.54M | 5.00M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 0.54M | 5.00M |
Low Estimate | NA | NA | 0.54M | 5.00M |
Year ago Sales | 0.00M | 0.00M | 0.00M | 0.54M |
Year over Year Growth Est. | NA | NA | 13,400.00% | 825.93% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -0.42 | -1.64 | -1.24 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.42 | -0.49 | -1.63 | -1.55 |
High Estimate | -0.42 | -0.35 | -1.63 | -0.93 |
Low Estimate | -0.48 | -0.49 | -1.65 | -1.55 |
Year ago EPS | -1.47 | -0.75 | -7.88 | -1.64 |
Year over Year Growth Est. | 69.39% | 44.00% | 79.19% | 24.39% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -0.42 | -1.64 | -1.24 |
7 Days Ago | -0.45 | -0.42 | -1.64 | -1.24 |
30 Days Ago | -0.45 | -0.42 | -1.64 | -1.24 |
60 Days Ago | -0.45 | -0.42 | -1.64 | -1.24 |
90 Days Ago | -0.46 | -0.52 | -1.46 | -1.27 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.42 | -1.64 | -1.24 |
Zacks Consensus Estimate | -0.45 | -0.42 | -1.64 | -1.24 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.61 | -0.63 | -0.75 | -1.47 | NA |
Estimate | -0.45 | -0.60 | -0.93 | -1.60 | NA |
Difference | -0.16 | -0.03 | 0.18 | 0.13 | 0.03 |
Surprise | -35.56% | -5.00% | 19.35% | 8.13% | -3.27% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more